![Coronavirus. le Nantais Jean-Luc Harousseau, ancien patron de la Haute Autorité de Santé, prescrit la chloroquine Coronavirus. le Nantais Jean-Luc Harousseau, ancien patron de la Haute Autorité de Santé, prescrit la chloroquine](https://france3-regions.francetvinfo.fr/image/TrCCxt1T3ZCGrm_StzKMrFsIWp4/930x620/regions/2020/06/09/5edfa00c1aa34_maxnewsworldthree332876-4716308.jpg)
Coronavirus. le Nantais Jean-Luc Harousseau, ancien patron de la Haute Autorité de Santé, prescrit la chloroquine
![PharmaBoardroom - Interview: Jean-Luc Harousseau - President, Haute Autorité de Santé (HAS; French National Authority for Health), France PharmaBoardroom - Interview: Jean-Luc Harousseau - President, Haute Autorité de Santé (HAS; French National Authority for Health), France](https://6erxg60qvo1qvjha44jrgpan-wpengine.netdna-ssl.com/wp-content/uploads/2015/12/Jean-Luc-Harousseau-Chairman-2011-2015-French-National-Authority-for-Health-HAS.jpg)
PharmaBoardroom - Interview: Jean-Luc Harousseau - President, Haute Autorité de Santé (HAS; French National Authority for Health), France
![Vincent Rajkumar on Twitter: "Two of the finest myeloma investigators. Ken Anderson and Jean Luc Harousseau https://t.co/QkaBxDONxR" / Twitter Vincent Rajkumar on Twitter: "Two of the finest myeloma investigators. Ken Anderson and Jean Luc Harousseau https://t.co/QkaBxDONxR" / Twitter](https://pbs.twimg.com/media/DfqWFJlWkAEc6yj.jpg:large)
Vincent Rajkumar on Twitter: "Two of the finest myeloma investigators. Ken Anderson and Jean Luc Harousseau https://t.co/QkaBxDONxR" / Twitter
![Daniel Auclair on Twitter: "Prof. Jean-Luc Harousseau at @COMyCongress #COMY20 on optimal choice of therapy in first #myeloma relapse. Many good triplets (including anti-CD38, elotuzumab, and next-gen PI and IMiDs-containing ones), multiple Daniel Auclair on Twitter: "Prof. Jean-Luc Harousseau at @COMyCongress #COMY20 on optimal choice of therapy in first #myeloma relapse. Many good triplets (including anti-CD38, elotuzumab, and next-gen PI and IMiDs-containing ones), multiple](https://pbs.twimg.com/media/EYJZZFtXYAI1jeF.jpg)
Daniel Auclair on Twitter: "Prof. Jean-Luc Harousseau at @COMyCongress #COMY20 on optimal choice of therapy in first #myeloma relapse. Many good triplets (including anti-CD38, elotuzumab, and next-gen PI and IMiDs-containing ones), multiple
Daniel Auclair on Twitter: "Prof. Jean-Luc Harousseau at @COMyCongress #COMY20 on optimal choice of therapy in first #myeloma relapse. Many good triplets (including anti-CD38, elotuzumab, and next-gen PI and IMiDs-containing ones), multiple
![Daniel Auclair on Twitter: "Prof. Jean-Luc Harousseau at @COMyCongress #COMY20 on optimal choice of therapy in first #myeloma relapse. Many good triplets (including anti-CD38, elotuzumab, and next-gen PI and IMiDs-containing ones), multiple Daniel Auclair on Twitter: "Prof. Jean-Luc Harousseau at @COMyCongress #COMY20 on optimal choice of therapy in first #myeloma relapse. Many good triplets (including anti-CD38, elotuzumab, and next-gen PI and IMiDs-containing ones), multiple](https://pbs.twimg.com/media/EYJZZFpXgAAsUXy.jpg:large)
Daniel Auclair on Twitter: "Prof. Jean-Luc Harousseau at @COMyCongress #COMY20 on optimal choice of therapy in first #myeloma relapse. Many good triplets (including anti-CD38, elotuzumab, and next-gen PI and IMiDs-containing ones), multiple
![Questions à. Jean-Luc Harousseau, président de la Haute autorité de santé : « L'évaluation des médicaments doit être revue » Questions à. Jean-Luc Harousseau, président de la Haute autorité de santé : « L'évaluation des médicaments doit être revue »](https://cdn-s-www.bienpublic.com/images/63E504F6-BAAC-48FD-932B-376744E4F888/MF_contenu/jean-luc-harousseau-president-de-la-haute-autorite-de-sante-l-evaluation-des-medicaments-doit-etre-revue-1412022196.jpg)